• Home
  • Pharmaceuticals and Healthcare
Global Biosimilar Lymphocyte Modulator Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Global Biosimilar Lymphocyte Modulator Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Report Code: KNJ1032167 | No. of Pages: 128 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: Nov-2021 
Executive Summary

According to GRD Survey data, the global Biosimilar Lymphocyte Modulator market is estimated at  million US$ in 2021 and is expected to reach  million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Biosimilar Lymphocyte Modulator market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Biosimilar Lymphocyte Modulator in these regions, from 2016 to 2027, covering
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
    Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
    South America (Brazil, Argentina, Colombia, etc.)
    Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
    Campath-1H

    Natalizumab Biosimilar

    Efalizumab-A1089-Anti-CD11a Bisoimilar

    Anti-CD38 Daratumumab Biosimilar

    Anti-CS1 Elotuzumab Bisoimilar

Market Snapshot, By Application
    Arthritis

    Diabetes

    Multiple Myeloma

    Enterocolitis

    Multiple Sclerosis

    Others

Main Market Players Analyzed in this report, including:
    Pfizer

    Novartis

    Genentech

    Celltrion

    Biogen


The study objectives of this report are:
    To study and analyze the global Biosimilar Lymphocyte Modulator market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
    To understand industry structure of Biosimilar Lymphocyte Modulator market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To identify the key global Biosimilar Lymphocyte Modulator manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Biosimilar Lymphocyte Modulator market with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Biosimilar Lymphocyte Modulator submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Biosimilar Lymphocyte Modulator are as follows:
    History Year: 2016-2020
    Base Year: 2020
    Estimated Year: 2021
    Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1  Market Definition & Scope
    1.1  Definition & Scope
    1.2 Biosimilar Lymphocyte Modulator Product Specifications
    1.3  Main Events (Entry, M&A, Exit, Technology and Capital Activity)
    1.4 Global Biosimilar Lymphocyte Modulator Market Performance and Outlook

2 Market Development Performance under COVID-19
    2.1 Influencing Factors of Industry Development in the Next Five Years
        2.1.1 Drivers
        2.1.2 Restraints
        2.1.3 Opportunities
    2.2 Porter’s Five Forces Analysis
    2.3 Comparison of Alternatives and Biosimilar Lymphocyte Modulator

3 Supply Chain and Manufacturing Cost Analysis
    3.1 Supply Chain Analysis
    3.2 Raw Materials and Key Suppliers Analysis
        3.2.1 Raw Materials Introduction
        3.2.1 Raw Materials Key Suppliers List
    3.3 Biosimilar Lymphocyte Modulator Sales Channel and Distributors Analysis
        3.3.1 Biosimilar Lymphocyte Modulator Sales Channel
        3.3.2 Biosimilar Lymphocyte Modulator Distributors
    3.4 Key Buying Industries/Consumers
        3.4.1 Major Buyers in Arthritis

        3.4.2 Major Buyers in Diabetes

    3.5 Biosimilar Lymphocyte Modulator Manufacturing Cost Structure Analysis

4 Market Segment: by Type
    4.1 Biosimilar Lymphocyte Modulator Type Introduction
        4.1.1 Campath-1H

        4.1.2 Natalizumab Biosimilar

        4.1.3 Efalizumab-A1089-Anti-CD11a Bisoimilar

        4.1.4 Anti-CD38 Daratumumab Biosimilar

        4.1.5 Anti-CS1 Elotuzumab Bisoimilar
    4.2 Global Biosimilar Lymphocyte Modulator Sales by Type 2016-2021
    4.3 Global Biosimilar Lymphocyte Modulator Revenue by Type 2016-2021
    4.4 Global Biosimilar Lymphocyte Modulator Price by Type 2016-2021

5 Market Segment: by Application
    5.1 Biosimilar Lymphocyte Modulator Type Introduction
        5.1.1 Arthritis

        5.1.2 Diabetes

        5.1.3 Multiple Myeloma

        5.1.3 Enterocolitis

        5.1.4 Multiple Sclerosis

        5.1.5 Others
    5.2 Global Biosimilar Lymphocyte Modulator Sales by Application 2016-2021
    5.3 Global Biosimilar Lymphocyte Modulator Revenue by Application 2016-2021
    5.4 Global Biosimilar Lymphocyte Modulator Price by Application 2016-2021

6 Marke Segment: by Region
    6.1 Global Biosimilar Lymphocyte Modulator Market by Region
        6.1.1 Global Biosimilar Lymphocyte Modulator Sales by Regions
        6.1.2 Global Biosimilar Lymphocyte Modulator Revenue by Regions
    6.2 North America Biosimilar Lymphocyte Modulator Market 2016-2021
    6.3 Europe Biosimilar Lymphocyte Modulator Market 2016-2021
    6.4 Asia Pacific Biosimilar Lymphocyte Modulator Market 2016-2021
    6.5 South America Biosimilar Lymphocyte Modulator Market 2016-2021
    6.6 Middle East and Africa Biosimilar Lymphocyte Modulator Market 2016-2021

7 North America
    7.1 North America Biosimilar Lymphocyte Modulator Market by Country 2016-2021
        7.1.1 North America Biosimilar Lymphocyte Modulator Sales by Country
        7.1.2 North America Biosimilar Lymphocyte Modulator Revenue by Country
    7.2 United States
    7.3 Canada
    7.4 Mexico

8 Europe
    8.1 Europe Biosimilar Lymphocyte Modulator Market by Country 2016-2021
        8.1.1 Europe Biosimilar Lymphocyte Modulator Sales by Country
        8.1.2 Europe Biosimilar Lymphocyte Modulator Revenue by Country
    8.2 Germany
    8.3 France
    8.4 UK
    8.5 Italy
    8.6 Russia
    8.7 Spain

9 Asia Pacific
    9.1 Asia Pacific Biosimilar Lymphocyte Modulator Market by Country 2016-2021
        9.1.1 Asia Pacific Biosimilar Lymphocyte Modulator Sales by Country
        9.1.2 Asia Pacific Biosimilar Lymphocyte Modulator Revenue by Country
    9.2 China
    9.3 Japan
    9.4 Korea
    9.5 Southeast Asia
    9.6 India
    9.7 Australia

10 South America
    10.1 South America Biosimilar Lymphocyte Modulator Market by Country 2016-2021
        10.1.1 South America Biosimilar Lymphocyte Modulator Sales by Country
        10.1.2 South America Biosimilar Lymphocyte Modulator Revenue by Country
    10.2 Brazil
    10.3 Argentina
    10.4 Colombia

11 Middle East and Africa
    11.1 Middle East and Africa Biosimilar Lymphocyte Modulator Market by Country 2016-2021
        11.1.1 Middle East and Africa Biosimilar Lymphocyte Modulator Sales by Country
        11.1.2 Middle East and Africa Biosimilar Lymphocyte Modulator Revenue by Country
    11.2 Turkey
    11.3 Saudi Arabia
    11.4 South Africa

12 Key Participants Company Information
    12.1 Pfizer

        12.1.1 Pfizer
 Company Information
        12.1.2 Pfizer
 Biosimilar Lymphocyte Modulator Product Portfolio, Specification and Application
        12.1.3 Pfizer
 Biosimilar Lymphocyte Modulator Sales, Price, Revenue and Gross Margin (2019-2021)
        12.1.4 Pfizer
 Key Development
    12.2 Novartis

        12.2.1 Novartis
 Company Information
        12.2.2 Novartis
 Biosimilar Lymphocyte Modulator Product Portfolio, Specification and Application
        12.2.3 Novartis
 Biosimilar Lymphocyte Modulator Sales, Price, Revenue and Gross Margin (2019-2021)
        12.2.4 Novartis
 Key Development
    12.3 Genentech

        12.3.1 Genentech
 Company Information
        12.3.2 Genentech
 Biosimilar Lymphocyte Modulator Product Portfolio, Specification and Application
        12.3.3 Genentech
 Biosimilar Lymphocyte Modulator Sales, Price, Revenue and Gross Margin (2019-2021)
        12.3.4 Genentech
 Key Development
    12.4 Celltrion

        12.4.1 Celltrion
 Company Information
        12.4.2 Celltrion
 Biosimilar Lymphocyte Modulator Product Portfolio, Specification and Application
        12.4.3 Celltrion
 Biosimilar Lymphocyte Modulator Sales, Price, Revenue and Gross Margin (2019-2021)
        12.4.4 Celltrion
 Key Development
    12.5 Biogen

        12.5.1 Biogen
 Company Information
        12.5.2 Biogen
 Biosimilar Lymphocyte Modulator Product Portfolio, Specification and Application
        12.5.3 Biogen
 Biosimilar Lymphocyte Modulator Sales, Price, Revenue and Gross Margin (2019-2021)
        12.5.4 Biogen
 Key Development

13 Global Biosimilar Lymphocyte Modulator Market Forecast by Region by Type and by Application
    13.1 Global Biosimilar Lymphocyte Modulator Sales, Revenue Forecast 2022-2027
    13.2 Global Biosimilar Lymphocyte Modulator Forecast by Regions
        13.2.1 Global Biosimilar Lymphocyte Modulator Sales Forecast by Region 2022-2027
        13.2.2 Global Biosimilar Lymphocyte Modulator Revenue Forecast by Region 2022-2027
    13.3 Global Biosimilar Lymphocyte Modulator Forecast by Type
        13.3.1 Global Biosimilar Lymphocyte Modulator Sales Forecast by Type 2022-2027
        13.3.2 Global Biosimilar Lymphocyte Modulator Revenue Forecast by Type 2022-2027
        13.3.3 Global Biosimilar Lymphocyte Modulator Price Forecast by Type 2022-2027
    13.4 Global Biosimilar Lymphocyte Modulator Forecast by Application
        13.4.1 Global Biosimilar Lymphocyte Modulator Sales Forecast by Application 2022-2027
        13.4.2 Global Biosimilar Lymphocyte Modulator Revenue Forecast by Application 2022-2027
        13.4.3 Global Biosimilar Lymphocyte Modulator Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
    15.1 Methodology
    15.2 Research Data Source
        15.2.1 Secondary Data
        15.2.2 Primary Data
        15.2.3 Market Size Estimation
    15.3 Legal Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com